607 related articles for article (PubMed ID: 15851027)
1. In vitro generation of infectious scrapie prions.
Castilla J; Saá P; Hetz C; Soto C
Cell; 2005 Apr; 121(2):195-206. PubMed ID: 15851027
[TBL] [Abstract][Full Text] [Related]
2. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
3. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
4. RNA molecules stimulate prion protein conversion.
Deleault NR; Lucassen RW; Supattapone S
Nature; 2003 Oct; 425(6959):717-20. PubMed ID: 14562104
[TBL] [Abstract][Full Text] [Related]
5. Protease-resistant prion protein in brain and lymphoid organs of sheep within a naturally scrapie-infected flock.
Madec JY; Groschup MH; Calavas D; Junghans F; Baron T
Microb Pathog; 2000 Jun; 28(6):353-62. PubMed ID: 10839972
[TBL] [Abstract][Full Text] [Related]
6. The role of glycophosphatidylinositol anchor in the amplification of the scrapie isoform of prion protein in vitro.
Kim JI; Surewicz K; Gambetti P; Surewicz WK
FEBS Lett; 2009 Nov; 583(22):3671-5. PubMed ID: 19854187
[TBL] [Abstract][Full Text] [Related]
7. Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases.
Jeong BH; Kim NH; Jin JK; Choi JK; Lee YJ; Kim JI; Choi EK; Carp RI; Kim YS
J Neuropathol Exp Neurol; 2009 Aug; 68(8):870-9. PubMed ID: 19606066
[TBL] [Abstract][Full Text] [Related]
8. In vitro prion protein conversion in detergent-solubilized membranes.
Nishina K; Deleault NR; Lucassen RW; Supattapone S
Biochemistry; 2004 Mar; 43(9):2613-21. PubMed ID: 14992599
[TBL] [Abstract][Full Text] [Related]
9. KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity.
Vetrugno V; Cardinale A; Filesi I; Mattei S; Sy MS; Pocchiari M; Biocca S
Biochem Biophys Res Commun; 2005 Dec; 338(4):1791-7. PubMed ID: 16288721
[TBL] [Abstract][Full Text] [Related]
10. Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres.
Kim NH; Choi JK; Jeong BH; Kim JI; Kwon MS; Carp RI; Kim YS
FASEB J; 2005 May; 19(7):783-5. PubMed ID: 15758042
[TBL] [Abstract][Full Text] [Related]
11. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.
Saborio GP; Permanne B; Soto C
Nature; 2001 Jun; 411(6839):810-3. PubMed ID: 11459061
[TBL] [Abstract][Full Text] [Related]
12. Prion protein conversion in vitro.
Supattapone S
J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
[TBL] [Abstract][Full Text] [Related]
13. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
Surewicz WK; Jones EM; Apetri AC
Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
[TBL] [Abstract][Full Text] [Related]
14. Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays.
Boerner S; Wagenführ K; Daus ML; Thomzig A; Beekes M
Lab Anim; 2013 Apr; 47(2):106-15. PubMed ID: 23479773
[TBL] [Abstract][Full Text] [Related]
15. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
[TBL] [Abstract][Full Text] [Related]
16. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
[TBL] [Abstract][Full Text] [Related]
17. Assessing the role of oxidized methionine at position 213 in the formation of prions in hamsters.
Silva CJ; Onisko BC; Dynin I; Erickson ML; Vensel WH; Requena JR; Antaki EM; Carter JM
Biochemistry; 2010 Mar; 49(9):1854-61. PubMed ID: 20121218
[TBL] [Abstract][Full Text] [Related]
18. Investigations of a prion infectivity assay to evaluate methods of decontamination.
Fichet G; Comoy E; Dehen C; Challier L; Antloga K; Deslys JP; McDonnell G
J Microbiol Methods; 2007 Sep; 70(3):511-8. PubMed ID: 17640752
[TBL] [Abstract][Full Text] [Related]
19. Detection of prions in blood.
Castilla J; Saá P; Soto C
Nat Med; 2005 Sep; 11(9):982-5. PubMed ID: 16127436
[TBL] [Abstract][Full Text] [Related]
20. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
